Fundraising FoxInflamalps
Valais, CH · 1 known investors
Find your way into Inflamalps
Sign up to see every warm intro you have to Inflamalps
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inflamalps team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Inflamalps is a biopharmaceutical company discovering anti-inflammatory and anti-microbial molecules, with its lead candidate INF101 targeting dry eye disease in ophthalmology. Since 2020 it has run a drug discovery program for novel anti-microbial molecules in partnership with academic and CRO partners across Europe and New Zealand.
Investors · 1
Frequently asked questions
- What does Inflamalps do?
- Inflamalps is a biopharmaceutical company discovering anti-inflammatory and anti-microbial molecules, with its lead candidate INF101 targeting dry eye disease in ophthalmology. Since 2020 it has run a drug discovery program for novel anti-microbial molecules in partnership with academic and CRO partners across Europe and New Zealand.
- Who are Inflamalps's investors?
- Inflamalps's investors include Waarde Capital.
- Where is Inflamalps headquartered?
- Inflamalps is headquartered in Valais, CH.